Smooth AdCom Passage Expected For Novo's Semaglutide Despite Retinopathy Queries

 
• By Lucie Ellis-Taitt
  
Monorail
Novo's semaglutide is speeding towards US launch before end of 2017 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category